Lexeo Therapeutics Inc. C...

NASDAQ: LXEO · Real-Time Price · USD
4.50
-0.29 (-6.05%)
At close: Aug 15, 2025, 3:08 PM

Lexeo Therapeutics Common Stock Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-2.13 -5.39 -4.27 -5
PEG Ratio
-0.09 -0.98 -0.25 -0.01
PS Ratio
n/a n/a 386.78 152.66
PB Ratio
1.79 3.15 -2.24 -4.55
P/FCF Ratio
-2.56 -5.99 -4.56 -5.7
P/OCF Ratio
-2.58 -6.01 -4.64 -5.73
OCF/S Ratio
n/a n/a -83.43 -26.66
Debt / Equity Ratio
0.08 0.10 -0.12 n/a
Quick Ratio
5.52 7.21 5.58 18.35
Current Ratio
5.52 7.21 5.58 18.35
Asset Turnover
n/a n/a 0.01 0.01
Interest Coverage
-927.77 -334.21 -664.93 n/a
Return on Equity
-0.84 -0.58 0.52 0.91
Return on Assets
-0.67 -0.47 -0.61 -0.37
Return on Invested Capital
-0.83 -0.55 -0.67 -0.39
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a n/a -0.75 0.99
Net Profit Margin
n/a n/a -90.64 -30.55
Pretax Profit Margin
n/a n/a -90.64 -30.55
Operating Profit Margin
n/a n/a -92.52 -30.56
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a n/a -88.75 -30.55